Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis

Introduction: Moderate hypofractionated (HF) radiotherapy is becoming the new standard in radiotherapy for prostate cancer patients. It is established as safe, but it might be associated with increased acute toxicity levels. We conducted a systematic review on moderate HF to establish acute toxicity...

Celý popis

Podrobná bibliografie

Hlavní autoři:	F. Sinzabakira, V. Brand, W.D. Heemsbergen, L. Incrocci
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2023-05-01
Edice:	Clinical and Translational Radiation Oncology
Témata:	Prostate cancer Radiotherapy Hypofractionation Toxicity
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S240563082300037X
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!